1. Home
  2. APYX vs AARD Comparison

APYX vs AARD Comparison

Compare APYX & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

N/A

Current Price

$2.92

Market Cap

107.4M

Sector

Health Care

ML Signal

N/A

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

N/A

Current Price

$1.64

Market Cap

97.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APYX
AARD
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
97.4M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
APYX
AARD
Price
$2.92
$1.64
Analyst Decision
Strong Buy
Hold
Analyst Count
6
11
Target Price
★ $6.50
$4.57
AVG Volume (30 Days)
142.0K
★ 1.2M
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
★ 43.11
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.42
N/A
Revenue Next Year
$11.05
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$0.93
52 Week High
$5.08
$16.60

Technical Indicators

Market Signals
Indicator
APYX
AARD
Relative Strength Index (RSI) 61.87 35.18
Support Level $2.82 $0.93
Resistance Level $3.20 $5.78
Average True Range (ATR) 0.20 0.32
MACD 0.06 0.08
Stochastic Oscillator 67.62 34.06

Price Performance

Historical Comparison
APYX
AARD

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: